A Study of Isatuximab-based Therapy in Participants With Lymphoma

Trial Identifier: ACT15320
Sponsor: Sanofi
Start Date: December 2018
Primary Completion Date: November 2022
Study Completion Date: November 2022
Condition: Lymphoma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
France DIJON, France, 21000
France MONTPELLIER, France, 34295
France Nantes, France, 44093
France PESSAC, France, 33600
France Villejuif, France, 94800
Italy, Bologna Bologna, Italy, 40138
Italy, Brescia Brescia, Italy, 25123
Italy, Milano Rozzano, Milano, Italy, 20089
Netherlands Amsterdam, Netherlands, 1081 HV
Netherlands Maastricht, Netherlands, 6229 HX
Portugal Coimbra, Portugal, 3000-075
Portugal Lisboa, Portugal, 1649-035
Portugal PORTO, Portugal, 4200
South Korea, Seoul-teukbyeolsi Gangnam-gu, Seoul-teukbyeolsi, South Korea, 06351
South Korea, Seoul-teukbyeolsi Seoul, Seoul-teukbyeolsi, South Korea, 03080
Spain, Barcelona [Barcelona] Barcelona, Barcelona [Barcelona], Spain, 08036
Spain, Barcelona [Barcelona] Barcelona, Barcelona [Barcelona], Spain, 08035
Spain, Barcelona [Barcelona] Hospitalet de Llobregat, Barcelona [Barcelona], Spain, 08908
Spain, Madrid, Comunidad de Madrid / Madrid, Madrid, Comunidad de, Spain, 28040
Taiwan Taichung, Taiwan, 40447